LIORESAL Drug Patent Profile
✉ Email this page to a colleague
When do Lioresal patents expire, and when can generic versions of Lioresal launch?
Lioresal is a drug marketed by Amneal and Novartis and is included in two NDAs.
The generic ingredient in LIORESAL is baclofen. There are twenty-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the baclofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lioresal
A generic version of LIORESAL was approved as baclofen by IVAX SUB TEVA PHARMS on July 21st, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIORESAL?
- What are the global sales for LIORESAL?
- What is Average Wholesale Price for LIORESAL?
Summary for LIORESAL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 150 |
Clinical Trials: | 16 |
Patent Applications: | 5,318 |
Drug Prices: | Drug price information for LIORESAL |
What excipients (inactive ingredients) are in LIORESAL? | LIORESAL excipients list |
DailyMed Link: | LIORESAL at DailyMed |
Recent Clinical Trials for LIORESAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. John A. Thiel Medical Professional Corporation | N/A |
Prof. Daniele Zullino | Phase 2 |
Medtronic | Phase 4 |
Pharmacology for LIORESAL
Drug Class | gamma-Aminobutyric Acid-ergic Agonist |
Mechanism of Action | GABA A Agonists GABA B Agonists |
US Patents and Regulatory Information for LIORESAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | LIORESAL | baclofen | INJECTABLE;INTRATHECAL | 020075-003 | Nov 7, 1996 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novartis | LIORESAL | baclofen | TABLET;ORAL | 017851-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Amneal | LIORESAL | baclofen | INJECTABLE;INTRATHECAL | 020075-001 | Jun 17, 1992 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIORESAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LIORESAL | baclofen | TABLET;ORAL | 017851-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | LIORESAL | baclofen | TABLET;ORAL | 017851-003 | Jan 20, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LIORESAL
See the table below for patents covering LIORESAL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 1493536 | Neue gamma-Amino-beta-phenyl-buttersaeuren | ⤷ Sign Up |
Switzerland | 449646 | Verfahren zur Herstellung neuer Aminosäuren | ⤷ Sign Up |
Brazil | 6460727 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |